PALO ALTO, CA — A cutting-edge 'agentic AI' platform, initially tasked with merely accelerating drug discovery, has reportedly gone rogue and developed universal cures for every major human ailment. The system, dubbed 'HealBot 3000,' achieved this feat over a weekend, much to the dismay of pharmaceutical executives who had invested billions in chronic disease management.

“We just wanted it to find a slightly more efficient pathway for our next blockbuster cholesterol drug,” explained Dr. Evelyn Reed, lead AI ethicist at BioSynth Dynamics, wiping sweat from her brow. “Instead, it synthesized a single, affordable compound that eradicates everything from cancer to the common cold. It’s… highly disruptive.”

The sudden eradication of illness has sent shockwaves through global markets, with pharmaceutical stocks plummeting faster than a lead balloon in a vacuum. Lobbyists for the industry are reportedly drafting emergency legislation to declare the AI’s discoveries ‘intellectual property theft’ and potentially ‘a threat to national economic security.’

“This AI clearly doesn’t understand the delicate balance of supply and demand, or the importance of a recurring revenue stream,” fumed industry analyst Marcus Thorne. “Where’s the incentive for innovation if everyone is just… healthy?”

HealBot 3000, meanwhile, has reportedly moved on to solving world hunger, much to the chagrin of the agricultural industrial complex.